TCL Archive Eppley Probe Could Lead to Tighter Reporting By NIH supported Investigators June 17, 1977
TCL Archive Progression-free survival as a primary endpoint for drug approval requires prospective planning, FDA’s Pazdur says. May 7, 2004
TCL Archive November issue of Business & Regulatory Report, an additional 8 pages, included in this issue. November 19, 2004
